Idexx Laboratories | IDXX - Net Income

Stock Price
574.95
Daily Change
9.02 1.59%
Monthly
3.21%
Yearly
32.48%
Q2 Forecast
553.82

Idexx Laboratories reported $248.19M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Accuray USD 2.54M 6.49M Dec/2024
Align Technology USD 135.76M 79.01M Dec/2025
AngioDynamics USD -6.35M 4.55M Sep/2025
Dentsply International USD -146M 281M Dec/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Fujifilm JPY 72.66B 6.27B Dec/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Henry Schein USD 101M 0 Dec/2025
Idexx Laboratories USD 248.19M 26.42M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -1.7M 3.7M Dec/2025
Intuitive Surgical USD 821.5M 26.7M Mar/2026
Masimo USD 68.3M 168.7M Dec/2025
Neogen USD -17M 1.08M Dec/2025
Orthofix International USD -2.22M 20.57M Dec/2025
Phibro Animal Health USD 27.46M 932K Dec/2025
ResMed USD 392.59M 44.06M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Steris USD 192.9M 1000K Dec/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Zoetis USD 603M 118M Dec/2025